Patent: 6,740,522
✉ Email this page to a colleague
Summary for Patent: 6,740,522
Title: | Antibodies against ligand for receptor activator of NF-kB |
Abstract: | Provided herein are antibodies that bind human RANKL polypeptides. |
Inventor(s): | Anderson; Dirk M. (Seattle, WA) |
Assignee: | Immunex Corporation (Seattle, WA) |
Application Number: | 09/865,363 |
Patent Claims: | see list of patent claims |
Details for Patent 6,740,522
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 06/01/2010 | ⤷ Try a Trial | 2016-12-23 |
Amgen, Inc. | XGEVA | denosumab | Injection | 125320 | 11/18/2010 | ⤷ Try a Trial | 2016-12-23 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,740,522
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | 401404 | ⤷ Try a Trial |
Austria | 412746 | ⤷ Try a Trial |
Austria | 497001 | ⤷ Try a Trial |
Austria | 517916 | ⤷ Try a Trial |
Australia | 3988899 | ⤷ Try a Trial |
Australia | 5618098 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |